Gsa Capital Partners LLP Nektar Therapeutics Transaction History

Gsa Capital Partners LLP

  • $1.32 Billion
  • Q3 2024

A detailed history of Gsa Capital Partners LLP transactions in Nektar Therapeutics stock. As of the latest transaction made, Gsa Capital Partners LLP holds 214,245 shares of NKTR stock, worth $194,962. This represents 0.02% of its overall portfolio holdings.

Number of Shares
214,245
Previous 930,943 76.99%
Holding current value
$194,962
Previous $1.15 Million 75.82%
% of portfolio
0.02%
Previous 0.08%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
SELL
$1.11 - $1.48 $795,534 - $1.06 Million
-716,698 Reduced 76.99%
214,245 $279,000
Q2 2024

Aug 15, 2024
SELL
$0.9 - $1.83 $953,065 - $1.94 Million
-1,058,962 Reduced 53.22%
930,943 $1.15 Million
Q1 2024

May 03, 2024
SELL
$0.49 - $0.96 $1.6 Million - $3.14 Million
-3,265,885 Reduced 62.14%
1,989,905 $1.85 Million
Q4 2023

Feb 16, 2024
BUY
$0.42 - $0.57 $1.43 Million - $1.95 Million
3,414,712 Added 185.47%
5,255,790 $2.94 Million
Q3 2023

Nov 15, 2023
BUY
$0.51 - $1.05 $847,920 - $1.75 Million
1,662,589 Added 931.48%
1,841,078 $1.1 Million
Q2 2023

Aug 14, 2023
SELL
$0.53 - $1.03 $993 - $1,930
-1,874 Reduced 1.04%
178,489 $103,000
Q1 2023

May 12, 2023
SELL
$0.64 - $3.15 $297,390 - $1.46 Million
-464,672 Reduced 72.04%
180,363 $126,000
Q4 2022

Feb 13, 2023
BUY
$2.03 - $4.28 $1.19 Million - $2.51 Million
585,748 Added 987.99%
645,035 $1.46 Million
Q3 2022

Nov 14, 2022
BUY
$3.04 - $5.14 $57,337 - $96,945
18,861 Added 46.66%
59,287 $190,000
Q2 2022

Aug 09, 2022
BUY
$3.17 - $6.17 $128,150 - $249,428
40,426 New
40,426 $154,000
Q1 2022

May 11, 2022
SELL
$4.16 - $13.72 $43,792 - $144,430
-10,527 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$10.83 - $18.41 $130,566 - $221,950
-12,056 Reduced 53.39%
10,527 $142,000
Q3 2021

Nov 12, 2021
SELL
$13.07 - $18.84 $850,543 - $1.23 Million
-65,076 Reduced 74.24%
22,583 $406,000
Q2 2021

Aug 05, 2021
BUY
$16.52 - $20.4 $1.45 Million - $1.79 Million
87,659 New
87,659 $1.5 Million
Q4 2020

Feb 03, 2021
SELL
$15.77 - $19.03 $471,664 - $569,168
-29,909 Closed
0 $0
Q3 2020

Nov 06, 2020
BUY
$16.59 - $24.79 $496,190 - $741,444
29,909 New
29,909 $496,000
Q4 2018

Feb 12, 2019
SELL
$30.43 - $56.65 $478,876 - $891,501
-15,737 Closed
0 $0
Q3 2018

Nov 13, 2018
SELL
$46.46 - $68.49 $39,444 - $58,148
-849 Reduced 5.12%
15,737 $959,000
Q2 2018

Aug 09, 2018
BUY
$46.25 - $104.45 $767,102 - $1.73 Million
16,586 New
16,586 $810,000
Q1 2018

May 11, 2018
SELL
$57.4 - $108.44 $817,146 - $1.54 Million
-14,236 Closed
0 $0
Q4 2017

Feb 14, 2018
SELL
$23.02 - $60.5 $1.07 Million - $2.8 Million
-46,362 Reduced 76.51%
14,236 $850,000
Q3 2017

Nov 20, 2017
BUY
$17.79 - $24.0 $1.08 Million - $1.45 Million
60,598
60,598 $1.45 Million

Others Institutions Holding NKTR

# of Institutions
145
Shares Held
139M
Call Options Held
32.6K
Put Options Held
14.1K
View Full List

About NEKTAR THERAPEUTICS

NKTR Quotes by TradingView
  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $171M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email